Abstract:OBJECTIVE:To investigate the changes of neutrophil myeloperoxidase (MPO) blood concentration gradient between the systemic circulation and the coronary circulation among patients with acute coronary syndrome and its clinical value. METHODS:Fifty patients underwent coronary angiography, which including 10 patients in AMI group, 20 patients in UA group, 10 patients in SA group and 10 subjects served as control. The levels of MPO and hs-CRP were measured in the serum of blood collected from femoral vein, aortic artery root and coronary sinus. RESULTS:Compared with the control, concentrations of LDL in the AMI, UA and SA groups were significantly increased, while the latter three groups did not differ from each other. In the UA patients, the in-gate percentage of MPO decreased in the coronary sinus compared with that in the root of aortic artery (P < 0.01); the in-gate percentage of MPO decreased through coronary circulation more than through systemic circulation (P < 0.001); the average fluorescent intensity of MPO and the concentrations of hs-CRP showed no difference between samples from the coronary sinus and that from the root of aortic artery. In the AMI patients, the average fluorescent intensity of MPO in the coronary sinus was weakened compared with that in the root of aortic artery (P < 0.05); it decreased through coronary circulation more than through systemic circulation (P < 0.001); neither the in-gate percentage of MPO nor the concentrations of hs-CRP showed significant difference between samples from the coronary sinus and that from the root of aortic artery. In the control and SA groups, samples from the femoral vein, the root of aortic artery, and the coronary sinus did not show differences at the serum level of MPO and hs-CRP. In the UA group, the in-gate percentage of MPO correlated positively with the concentration of hs-CRP (r = 0.78, P < 0.01), and with the level of LDL as well (r = 0.52, P < 0.05); In the AMI group, the average fluorescent intensity of MPO correlated negatively with the concentration of hs-CRP (r = -0.80, P < 0.01), and showed no correlation with the level of LDL (r = 0.22, P > 0.05). CONCLUSIONS:MPO is a better marker for inflammation of the local plaques. It may be one of the mechanisms that MPO induces the transforming from LDL to ox-LDL in plaques vulnerability.

Probucol reduces myeloperoxidase expression in peripheral blood monocytes from patients with acute coronary syndrome

Abstract 288: Atheroprotective Effect of Probucol is Related to Its Heme Oxygenase 1 Activation and Subsequent Suppression of Oxidized Low-Density Lipoprotein--Induced Dendritic Cell Maturation

E0325 Influence of Probucol on Endothelial Dependent Vasodilation Reaction in Patients with Acute Coronary Syndrome

Probucol Protects Endothelial Progenitor Cells Against Oxidized Low-Density Lipoprotein via Suppression of Reactive Oxygen Species Formation In Vivo.

Beneficial Effects of Probucol on Endothelial Function in Patients with Acute Coronary Syndrome

Probucol Decreases Asymmetrical Dimethylarginine Level by Alternation of Protein Arginine Methyltransferase I and Dimethylarginine Dimethylaminohydrolase Activity

Effects of Probucol in plasma ox-LDL and hs-CRP in patients with acute coronary syndrome

Abstract P298: Probucol Inhibits Oxidized Low-Density Lipoprotein--Induced Immune Maturation of Dendritic Cells Via Heme Oxygenase 1

Probucol inhibits LPS-induced microglia activation and ameliorates brain ischemic injury in normal and hyperlipidemic mice

Probucol Up-Regulates Paraoxonase 1 Expression in Hepatocytes of Hypercholesterolemic Rabbits

Probucol alleviates atherosclerosis and improves high density lipoprotein function

Changes of Neutrophil Myeloperoxidase in Coronary Circulation among Patients with Acute Coronary Syndrome

Probucol Inhibits Atherosclerosis by Regulating ABCA1, SR-B I, ABCG5 and ABCG8 Expression and Anti-inflammatory Effects in Hypercholesterolemic Rabbits

Effects of Probucol on the Levels of Anti-Oxidized LDL Auto-Antibodies and Matrix Metalloproteinase-9 in Acute Stage of Cerebral Infarction

Probucol Protects Against Atherosclerosis Through Induction of Heme Oxygenase-1

Paradoxical enhancement of atherosclerosis by probucol treatment in apolipoprotein E-deficient mice.

Remedy of redox status imbalance with probucol in patients with coronary heart disease

Probucol Inhibits Expression of CD36 Induced by Oxidized Low-density Lipoprotein in Macrophages

Effect of Probucol on Adhesion of Human Monocytic Line THP-1 Induced by Oxidiz Ed Low Density Lipoprotein

New insights into mechanism for the effect of probucol in anti-atherosclerosis: Possible role of inhibitor on immune maturation of dendritic cells

Effect of the Anti-Oxidant Probucol on Soluble Thrombomodulin (stm) in Hypercholesterolemic Rabbits